Comparative safety of tyrosine kinase inhibitors in the treatment of metastatic renal cell carcinoma: a systematic review and network meta-analysis

Objective: This study aimed to compare the safety profile of tyrosine kinase inhibitors (TKIs) approved for use as monotherapy or combination therapy for the first-line treatment of adult patients with metastatic clear cell renal cell carcinoma (RCC). Methods: A systematic review with frequentist ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Krawczyk, Kinga, Śladowska, Katarzyna, Holko, Przemysław, Kawalec, Paweł
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512702/
https://www.ncbi.nlm.nih.gov/pubmed/37745049
http://dx.doi.org/10.3389/fphar.2023.1223929

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10512702/
https://www.ncbi.nlm.nih.gov/pubmed/37745049
http://dx.doi.org/10.3389/fphar.2023.1223929

Ejemplares similares